The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

Myelodysplastic syndromes (MDS) represent one of the most frequent and serious haematologic diseases of the elderly. Effective therapies exist ranging from best supportive care to haematologic stem cell transplantation (HSCT). Decision making, however, is rather complex in this group of patients bec...

Descripción completa

Detalles Bibliográficos
Autor principal: Stauder, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411309/
https://www.ncbi.nlm.nih.gov/pubmed/22547053
http://dx.doi.org/10.1007/s00277-012-1472-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411309/
https://www.ncbi.nlm.nih.gov/pubmed/22547053
http://dx.doi.org/10.1007/s00277-012-1472-8

Ejemplares similares